perfluorobutane has been researched along with Coronary Restenosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abizaid, A; Colombo, A; Dangas, G; Hellinga, D; Iversen, P; Iyer, S; Kipshidze, NN; Leon, MB; Moses, JW; Porter, TR; Roubin, G; Seabron, R; Tio, F; Waksman, R; Wolfram, R; Xie, F; Yazdi, H | 1 |
1 other study(ies) available for perfluorobutane and Coronary Restenosis
| Article | Year |
|---|---|
Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model.
Topics: Animals; Blood Vessel Prosthesis Implantation; Blotting, Western; Cell Cycle Proteins; Chromatography, High Pressure Liquid; Coronary Restenosis; Coronary Vessels; Cyclin-Dependent Kinase Inhibitor p27; Disease Models, Animal; Drug Delivery Systems; Fluorocarbons; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intra-Arterial; Microbubbles; Sirolimus; Stents; Swine; Tumor Suppressor Proteins; Tunica Intima | 2005 |